Gabilondo-Navarro F

Language: Spanish
References: 10
Page: 61-63
PDF size: 203.59 Kb.

Text Extraction

No abstract..

REFERENCES

1. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011; 43 (1): 376-379.

2. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term

3. Pérez-Sáez MJ, Canal C, Cofan F, Errasti P, Jimeno L, López-Oliva M et al. Epidemiología del cáncer en el trasplante renal: incidencia, prevalencia y factores de riesgo. Nefrología Sup Ext. 2018; 9 (1): 24-36. outcomes. Transplantation. 2013; 95 (2): 267-274.

4. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009; 24 (10): 3225-3231.

5. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004; 4 (6): 905-913.

6. Ochoa-López JM, Gabilondo-Pliego B, Collura-Merlier S, Herrera-Cáceres JO, de Zavaleta MS, Rodríguez-Covarrubias FT et al. Incidence and treatment of malignant tumors of the genitourinary tract in renal transplant recipients. Int Braz J Urol. 2018; 44 (5): 874-881.

7. Tillou X, Doerfler A. Urological tumors in renal transplantation. Minerva Urol Nefrol. 2014; 66 (1): 57-67.

8. Campistol JM, Morales JM. Manejo de tumores tras el trasplante renal. Nefrología. 2009; 29 (Sup. Ext. 2): 33-45.

9. Tsaur I, Karalis A, Probst M, Blaheta RA, Scheuermann EH, Gossmann J et al. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center. Cancer Sci. 2010; 101 (11): 2430-2435.

10. Besarani D, Cranston D. Urological malignancy after renal transplantation. BJU Int. 2007; 100 (3): 502-505.